Richards A.: How the body's immune system functions. US Pharm13:38-50, 1988
2.
Turner M.: Molecules which recognize antigen, in Roitt 1, Brostoff J, Male D (eds): Immunology. New York, NY , Gower Medical, 1989 , pp 5.3-5.6
3.
Dawson M., Moore M.: Tumor immunology, in Roitt I, Brostoff J, Male D (eds): Immunology, New York, NY, Gower Medical, 1989, p 18.17
4.
Mossinghoff G. : Biotechnology medicines. Pharmaceutical Manufacturer's Association, May, 1990
5.
Kohler G., Milstein C.: Continuous cultures of fused cells secreting antibody of predefined specificity . Nature256:495-497,1975
6.
Tami JA, Parr MD, Brown SA, et al: Monoclonal antibody technology. Am J Hosp Pharm43:2816-2825, 1986
7.
Lewis R.: Novel monoclonal method receives praise. Genet Engineer News Feb 1, 1990, p 1
8.
Mally M.: Genetic engineering in human lymphocytes for the production of monoclonal antibodies. Hum Antibod Hybridomas1:27-33, 1990
9.
Van Brunt J. : Monoclonal fine-tuning continues in coli. Bio/Tech8:276, 1990
10.
Huse WD, Sastry L., Iverson SA, et al: Generation of large combinatorial library of the immunoglobulin repertoire in phage lambda. Science246:1275-1281, 1989
11.
Bogard WC, Dean RT, Deo Y., et al: Practical considerations in the production, purification, and formulation of monoclonal antibodies for immunoscintigraphy and immunotherapy. Semin Nucl Med14:202-220, 1989
12.
Prince DL, Prince RN: Quality assurance of monoclonal products: virologic and molecular biologic considerations. J Industrial Microbiol3:157-165, 1980
13.
Rhodes W.: Characterization and quality assurance of hybridoma cell lines. Pharm Manu2:14-15,1985
14.
Kessler D.: The regulation of investigational drugs. N Engl J Med320:281-288,1989
15.
McCombs J.: Home pregnancy tests. PharmTimes September:35-37, 1989
Fritzberg AR , Berninger RW, Hadley SW, et al: Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer. Pharm Res5:325-334, 1988
19.
Smith TW, Butler VP, Haber E., et al: Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. N Engl J Med307:1357-1362, 1982 20. Curd J., Smith TW, Jaton JC, et al: The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin . Proc Natl Acad Sci USA68:2401-2406, 1971
20.
Hunger MM, Margolies MN, Ju A., et al: High-affinity monoclonal antibodies to the cardiac glycoside, digoxin. J Immunol129:1165-1172, 1982
21.
Butler V.: Development of digibind. Management of Digitalis Toxicity, Monograph . Burroughs Wellcome Co, Research Triangle Park, NC, September:33, 1986
22.
Muromonab-CD3 Facts and Comparisons. June:38f, 1990
23.
Ortho Multicenter Transplant Study Group : A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med313:337-342, 1985
24.
Ziegler E., Fisher C., Sprung C., et al: Prevention of death from gram negative bacteremia and sepsis by HA-1A, a human monoclonal antibody specific for lipid A of endotoxin: Results of Phase III trial. Clin Res38:304A, 1990
25.
Foon K.: Monoclonal Antibodies in the Diagnosis and Treatment of Cancer. Seattle, WA, NeoRx Corp, 1989
